Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2020

Ausgabe 3/2020

Inhaltsverzeichnis ( 20 Artikel )

24.04.2020 | COVID-19 | Editorial | Ausgabe 3/2020 Open Access

Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium

Jill R. Dietz, Meena S. Moran, Steven J. Isakoff, Scott H. Kurtzman, Shawna C. Willey, Harold J. Burstein, Richard J. Bleicher, Janice A. Lyons, Terry Sarantou, Paul L. Baron, Randy E. Stevens, Susan K. Boolbol, Benjamin O. Anderson, Lawrence N. Shulman, William J. Gradishar, Debra L. Monticciolo, Donna M. Plecha, Heidi Nelson, Katharine A. Yao

06.05.2020 | Review | Ausgabe 3/2020 Open Access

Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review

Ena Niño de Guzmán, Yang Song, Pablo Alonso-Coello, Carlos Canelo-Aybar, Luciana Neamtiu, Elena Parmelli, Javier Pérez-Bracchiglione, Montserrat Rabassa, David Rigau, Zuleika Saz Parkinson, Iván Solà, Adrián Vásquez-Mejía, Ignacio Ricci-Cabello

25.04.2020 | Preclinical study | Ausgabe 3/2020

HER2 intratumoral heterogeneity is independently associated with distal metastasis and overall survival in HER2-positive breast carcinomas

Tiansheng Shen, Hiroaki Nitta, Lai Wei, Anil V. Parwani, Zaibo Li

27.04.2020 | Preclinical study | Ausgabe 3/2020

MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients

Brian G. Hunt, Christina A. Wicker, Jennifer R. Bourn, Elyse E. Lower, Vinita Takiar, Susan E. Waltz

29.04.2020 | Preclinical Study | Ausgabe 3/2020 Open Access

Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer

Abrar I. Aljohani, Chitra Joseph, Sasagu Kurozumi, Omar J. Mohammed, Islam M. Miligy, Andrew R. Green, Emad A. Rakha

02.05.2020 | Preclinical study | Ausgabe 3/2020

PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies

E. S. Stovgaard, M. Bokharaey, K. List-Jensen, A. Roslind, I. Kümler, E. Høgdall, D. Nielsen, E. Balslev

02.05.2020 | Preclinical study | Ausgabe 3/2020

Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study

Ruo-Xi Wang, Peng Ji, Yue Gong, Zhi-Ming Shao, Sheng Chen

06.05.2020 | Preclinical study | Ausgabe 3/2020 Open Access

Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy

Sharon A. O’Toole, Cathy Spillane, Yanmei Huang, Marie C. Fitzgerald, Brendan Ffrench, Bashir Mohamed, Mark Ward, Michael Gallagher, Tanya Kelly, Cathal O’Brien, Carmel Ruttle, Anna Bogdanska, Cara Martin, Dorinda Mullen, Elizabeth Connolly, Sarah A. McGarrigle, John Kennedy, John J. O’Leary

24.04.2020 | Clinical trial | Ausgabe 3/2020 Open Access

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

Inge-Marie Obdeijn, Ritse M. Mann, Claudette C. E. Loo, Marc Lobbes, Eleonora M. C. Voormolen, Carolien H. M. van Deurzen, Geertruida de Bock, Maartje J. Hooning, Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON)

27.04.2020 | Clinical trial | Ausgabe 3/2020

Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts

Mengmeng Jia, Xi Lin, Xiang Zhou, Huijiao Yan, Yaqing Chen, Peifang Liu, Lingyun Bao, Anhua Li, Partha Basu, Youlin Qiao, Rengaswamy Sankaranarayanan

28.04.2020 | Clinical trial | Ausgabe 3/2020 Open Access

Breast sensibility in bilateral autologous breast reconstruction with unilateral sensory nerve coaptation

Ennie Bijkerk, Sander M. J. van Kuijk, Arno Lataster, René R. W. J. van der Hulst, Stefania M. H. Tuinder

30.04.2020 | Clinical trial | Ausgabe 3/2020

A prospective cohort study to analyze the interaction of tumor-to-breast volume in breast conservation therapy versus mastectomy with reconstruction

Utku Dolen, Melissa Thornton, Marissa M. Tenenbaum, Allison Aripoli, Amy Patel, Amy E. Cyr, Yan Yan, Catherine M. Appleton, Julie A. Margenthaler, Terence M. Myckatyn

06.05.2020 | Clinical trial | Ausgabe 3/2020

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

Peter H. O’Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, Julianne P. Hall, Aritro Nath, Dezheng Huo, Gini F. Fleming, James N. Ingle, Vandana G. Abramson, P. K. Morrow, Anna Maria Storniolo, Andres Forero, Catherine Van Poznak, Minetta C. Liu, Jenny C. Chang, Douglas E. Merkel, Jeffrey M. Peppercorn, Hope S. Rugo, E. Claire Dees, Olwen M. Hahn, Philip C. Hoffman, Gary L. Rosner, R. Stephanie Huang, Mark J. Ratain, Nancy Cox, Olufunmilayo I. Olopade, Antonio C. Wolff, M. Eileen Dolan, Rita Nanda, the Translational Breast Cancer Research Consortium (TBCRC)

06.05.2020 | Clinical trial | Ausgabe 3/2020

Assessing breast lymphoedema following breast cancer treatment using indocyanine green lymphography

Asha Heydon-White, Hiroo Suami, John Boyages, Louise Koelmeyer, Karen C. Peebles

07.05.2020 | Clinical trial | Ausgabe 3/2020 Open Access

Chemotherapy use near the end-of-life in patients with metastatic breast cancer

Luisa Edman Kessler, Johnny Sigfridsson, Dora Hatzidaki, Jonas Bergh, Theodoros Foukakis, Vasilios Georgoulias, Alexios Matikas

28.04.2020 | Epidemiology | Ausgabe 3/2020

Medical costs associated with metastatic breast cancer in younger, midlife, and older women

Justin G. Trogdon, Christopher D. Baggett, Anagha Gogate, Katherine E. Reeder-Hayes, Jason Rotter, Xi Zhou, Donatus U. Ekwueme, Temeika L. Fairley, Stephanie B. Wheeler

30.04.2020 | Epidemiology | Ausgabe 3/2020 Open Access

Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study

Inés Gómez-Acebo, Trinidad Dierssen-Sotos, Camilo Palazuelos-Calderón, Beatriz Pérez-Gómez, Pilar Amiano, Marcela Guevara, Antonio J. Molina, Laia Domingo, María Fernández-Ortiz, Victor Moreno, Juan Alguacil, Guillermo Fernández-Tardón, Josefa Ibáñez, Rafael Marcos-Gragera, Marian Diaz-Santos, M. Henar Alonso, Jessica Alonso-Molero, Gemma Castaño-Vinyals, Andrés García Palomo, Eva Ardanaz, Amaia Molinuevo, Nuria Aragonés, Manolis Kogevinas, Marina Pollán, Javier Llorca

04.05.2020 | Epidemiology | Ausgabe 3/2020

Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors

Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M. Abu-Khalaf, Daniel P. Silver, Juan P. Palazzo, Geetha Jagannathan, Frederick M. Fellin, Saveri Bhattacharya, Rebecca J. Jaslow, Theodore N. Tsangaris, Adam Berger, Manish Neupane, Terrence P. Cescon, AnaMaria Lopez, Kaelan Yao, Weelic Chong, Brian Lu, Ronald E. Myers, Lifang Hou, Qiang Wei, Bingshan Li, Massimo Cristofanilli, Hushan Yang

27.04.2020 | Letter to the Editor | Ausgabe 3/2020

Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?

Kadri Altundag

29.04.2020 | Letter to the Editor | Ausgabe 3/2020

Anti-HER2 therapy for metastatic breast cancer in low- and middle-income countries: bridging the gap between clinical trials and real life

Leonardo Ribeiro Soares, Victor Domingos Lisita Rosa, Ruffo Freitas-Junior

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise